Algorithm Under the Microscope: Aiforia and Proscia Unite AI Pathology

On March 10, 2026, two key companies in the digital medicine sector—Aiforia and Proscia—announced a strategic merger of their ecosystems. The goal of the partnership is the seamless integration of neural network biopsy analysis into the clinical workflows of hospitals.

Digital anatomical pathology has long suffered from software fragmentation. Integrating Aiforia's diagnostic AI models directly into Proscia's central platform (Concentriq) solves the standardization problem. Doctors get a "single pane of glass" where the computer vision system automatically highlights malignant cells on histological slides, sorting cases by severity. This is a classic example of how domain-specific B2B models save lives by accelerating diagnosis and eliminating the human factor from routine triage.

Source: Aiforia / Reuters